WASHINGTON, D.C. — US health authorities on Thursday approved updated versions of Pfizer and Moderna's Covid-19 vaccines, with the companies saying the jabs will be available "in the coming days."
The latest vaccines, developed using the KP.2 variant of the virus, are designed to target variants currently in circulation and provide better protection against the risks of hospitalization or death, the US Food and Drug Administration (FDA) said.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.